Publications
Export 23 results:
Filters: Keyword is Intermediate Filament Proteins [Clear All Filters]
“Giant axonal neuropathy-associated gigaxonin mutations impair intermediate filament protein degradation.”, J Clin Invest, vol. 123, no. 5, pp. 1964-75, 2013.
, “Peripherin is a subunit of peripheral nerve neurofilaments: implications for differential vulnerability of CNS and peripheral nervous system axons.”, J Neurosci, vol. 32, no. 25, pp. 8501-8, 2012.
, “Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.”, Brain, vol. 134, no. Pt 9, pp. 2610-26, 2011.
, “Distinct biochemical signatures characterize peripherin isoform expression in both traumatic neuronal injury and motor neuron disease.”, J Neurochem, vol. 114, no. 4, pp. 1177-92, 2010.
, “Type III intermediate filament peripherin inhibits neuritogenesis in type II spiral ganglion neurons in vitro.”, Neurosci Lett, vol. 478, no. 2, pp. 51-5, 2010.
, “Real-time imaging reveals defects of fast axonal transport induced by disorganization of intermediate filaments.”, FASEB J, vol. 23, no. 9, pp. 3213-25, 2009.
, “Modest loss of peripheral axons, muscle atrophy and formation of brain inclusions in mice with targeted deletion of gigaxonin exon 1.”, J Neurochem, vol. 107, no. 1, pp. 253-64, 2008.
, “The type III neurofilament peripherin is expressed in the tuberomammillary neurons of the mouse.”, BMC Neurosci, vol. 9, p. 26, 2008.
, “Neuronal expression of peripherin, a type III intermediate filament protein, in the mouse hindbrain.”, Histochem Cell Biol, vol. 128, no. 6, pp. 541-50, 2007.
, “Alpha-internexin is structurally and functionally associated with the neurofilament triplet proteins in the mature CNS.”, J Neurosci, vol. 26, no. 39, pp. 10006-19, 2006.
, “Defective axonal transport of neurofilament proteins in neurons overexpressing peripherin.”, J Neurochem, vol. 98, no. 3, pp. 926-38, 2006.
, “Cytoskeletal defects in amyotrophic lateral sclerosis (motor neuron disease).”, Novartis Found Symp, vol. 264, pp. 183-92; discussion 192-6, 227-30, 2005.
, “Up-regulation of peripherin is associated with alterations in synaptic plasticity in CA1 and CA3 regions of hippocampus.”, Neurobiol Dis, vol. 18, no. 2, pp. 409-20, 2005.
, “[35S]Methionine metabolic labeling to study axonal transport of neuronal intermediate filament proteins in vivo.”, Methods Cell Biol, vol. 78, pp. 555-71, 2004.
, “Evidence of newly generated neurons in the human olfactory bulb.”, Brain Res Dev Brain Res, vol. 151, no. 1-2, pp. 159-68, 2004.
, “A frameshift deletion in peripherin gene associated with amyotrophic lateral sclerosis.”, J Biol Chem, vol. 279, no. 44, pp. 45951-6, 2004.
, “Autosomal dominant macular dystrophy in a large Canadian family.”, Can J Ophthalmol, vol. 38, no. 1, pp. 33-40, 2003.
, “Neurofilament transport in vivo minimally requires hetero-oligomer formation.”, J Neurosci, vol. 23, no. 28, pp. 9452-8, 2003.
, “A neurotoxic peripherin splice variant in a mouse model of ALS.”, J Cell Biol, vol. 160, no. 6, pp. 939-49, 2003.
, “Peripherin is not a contributing factor to motor neuron disease in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase.”, Neurobiol Dis, vol. 13, no. 2, pp. 158-66, 2003.
, “Peripherin-mediated death of motor neurons rescued by overexpression of neurofilament NF-H proteins.”, J Neurochem, vol. 85, no. 1, pp. 248-56, 2003.
, “Induction of peripherin expression in subsets of brain neurons after lesion injury or cerebral ischemia.”, Brain Res, vol. 946, no. 2, pp. 153-61, 2002.
, “Pathways to motor neuron degeneration in transgenic mouse models.”, Biochimie, vol. 84, no. 11, pp. 1151-60, 2002.
,